Cargando...
Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
Aberrant expression of CD19 in acute myeloid leukemia (AML) is commonly associated with t(8;21)(q22;q22), although AML cases lacking this translocation occasionally express CD19. Mixed-phenotype acute leukemia also frequently expresses CD19. Chimeric antigen receptor (CAR) technology is a major brea...
Guardado en:
| Publicado en: | Leuk Res Rep |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5993359/ https://ncbi.nlm.nih.gov/pubmed/29892548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2018.03.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|